James M. Inhofe sold Johnson & Johnson (NYSE: JNJ)
James M. Inhofe (R-OK), a U.S. Senator, has disclosed 1 trade in Johnson & Johnson (JNJ) since 2017, a single sale, worth an estimated $75K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James M. Inhofe sold $50,001 - $100,000 of Johnson & Johnson (NYSE: JNJ) on June 9, 2017. Since that trade, JNJ is up +158.44% against the S&P 500 up +245.61%, an outperformance of -87.17%.
Data updated
James M. Inhofe's JNJ trades vs the price
JNJ is up +158.44% since James M. Inhofe sold on June 9, 2017, versus +245.61% for the S&P 500.
Performance since this trade
All James M. Inhofe JNJ trades
James M. Inhofe & JNJ trading FAQ
Is it legal for James M. Inhofe to trade Johnson & Johnson (JNJ) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Johnson & Johnson (JNJ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James M. Inhofe sell JNJ?
James M. Inhofe disclosed a sale of $50,001 - $100,000 of Johnson & Johnson (JNJ) on June 9, 2017, according to public STOCK Act filings.
How has JNJ performed since James M. Inhofe's trade?
Since James M. Inhofe sold JNJ on June 9, 2017, the stock is up +158.44%, versus +245.61% for the S&P 500 over the same period, an outperformance of -87.17%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional JNJ trades?
Quantellect tracks every disclosed congressional trade in Johnson & Johnson (JNJ) on the Johnson & Johnson congressional trading page, which aggregates filings across all members of Congress.
James M. Inhofe's JNJ tradesAll congressional filings for Johnson & JohnsonJames M. Inhofe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.